E1: US Response to COVID-19 & Impact on Startups, Venture Capital & Public Markets with David Friedberg

Follow @chamath: https://twitter.com/chamath Follow @jason: https://twitter.com/Jason https://linktr.ee/calacanis 0:01 Jason & Chamath intro David and check in on each other's quarantines 2:26 Has the US overreacted or underreacted so far? David & Chamath give their opinions on new directives & statistics 13:15 Thoughts on potential treatment options & policy changes 22:25 Chamath explains the circumstances of recording a podcast while the Stock Market tanks in real-time 25:03 Should the US adopt Chinese & South Korean quarantine strategies? 29:53 What do the current market conditions mean for startups & VC? 41:24 Chamath explains what is currently happening in the capital markets 45:05 How close is the US on being able to do mass-testing? 54:13 Thoughts on bailouts for companies that manipulated their earnings-per-share ratio by stock buybacks? Impact on the global economy 1:03:14 Impact on luxury goods? Should there be a monthly stipend for low-income citizens? 1:12:10 COVID-19 exposing holes in the US healthcare system 1:17:44 Should we ban wet markets globally? 1:24:12 Over/Under: when Americans will be allowed to go out to restaurants again 1:28:18 When will the weekly poker game resume?

Speaker names marked ? are inferred from speaking time and the show’s known hosts — they are not voice-verified.

• 0:00Jason Calacanis?

  All right, everybody. Welcome to another edition of the All In Podcast. We'll call this Episode One. We did a test and over 100,000 of you listened to the test podcast that we did. In a few days. In a few days. Chamath is already getting addicted to his statistics, a new podcaster. I need to focus on something going up. Yes, exactly. Our portfolios are getting crushed, but the podcast numbers are going up. They're a meaningless victory, to be sure. But we got a lot of positive feedback and we're all sitting at home in quarantine. As you can see, I set up my home office. I got a microphone here and Chamath is in his bedroom and David Friedberg, I think, is in his wine room or something in his, in his compound. Are you in the safe room? Is this the safe

• 0:45Jason Calacanis?

  room? David Friedberg is with us again. He got a lot of great feedback and he's now on the Twitter. You can follow him @Friedberg. I don't know if he shut his Twitter down because he was getting harassed on Twitter. Welcome to the club. Are you in your safe room, David?

• 0:59David Friedberg?

  Yeah, it's brutal on Twitter. I don't know how you guys do it. You put something up and everyone, you know, just goes after you. It's harsh out there in the Twitter world, the Twitterverse.

• 1:09Jason Calacanis?

  Basically, you have to mute and block anybody who is under 100 followers and being an absolute jerk because it's likely a Russian bot, you know, being run out of like Manila or something like that. They've got all these like sophisticated rings of people that they just hire for 10 bucks a day to harass people online. I mean, I know it sounds like a crazy conspiracy theory, but it's actually true. This large groups of bots who go after people and try to create chaos. But hey, we're sitting here. It's, today's Wednesday. We did our podcast on Saturday. The stock market has gone down another 20% since then, I guess,

• 1:51Jason Calacanis?

  or so. And we are looking like this is going to be a 50% correction or something like that. We're now, you know, well past a 30-plus percent. And on the good news front, it looks like testing is actually occurring and that work on Work on treatments is occurring, I don't know if we can call them cures, but treatments is occurring and quarantine in place is being taken seriously and I guess the biggest thing is that Trump has basically admitted that this is a crisis and he's taking it seriously. Friedberg, what is your assessment of where we are today versus when we taped on Saturday

• 2:33Jason Calacanis?

  in terms of the resolution to this? Are we overreacting, reacting just enough or not reacting enough?

• 2:41David Friedberg?

  There's three things to consider: the health, the policy, and then the markets. On the health front, it seems like we have done a lot in terms of containment and we're ramping up testing. We are still not doing broad general population testing, which is necessary for us to truly understand the dynamics of this disease and also to understand the contagion of this disease and we need to fix that problem. There's a task force of 100 people out of DC being led by Jared Kushner and a number of people from the tech industry that are working on ramping up testing and doing broader general population testing. The policy decisions are what get quite scary and that is all of the containment, shutting down travel, shutting down borders, shutting down bridges, and the economic ramifications

• 3:26David Friedberg?

  of doing so are frightening. I think I mentioned the other day that 48% roughly of the US workforce works in small businesses, another roughly 10% work in travel, another roughly 12% work in energy, and you know, you kind of add this up and you can quickly see why Steve Mnuchin, the US Treasury Secretary, was saying that we should expect 20 to 30% of the workforce to be unemployed by this summer if we keep this up. So that is a frustrating and staggering statistic and something worth debating whether that policy decision is appropriate relative to the potential life and health and health system impact, you know, which one is worse. And then the market question is just, I don't know how to address

• 4:10David Friedberg?

  that, but things go from bad to worse, right?

• 4:15Chamath Palihapitiya?

  I have eight things that I want to cover today.

• 4:19David Friedberg?

  Hold on, hold on, we'll take one thing at a time here. Everybody's warrant to go. I want to say one more thing, and it is, I think, the most important data to come out today. So, the markets are fucked, we're all in trouble, we're, you know, yada, yada. The most scary thing is Ford and GM just shut down their plants today. And the reason they shut down their plants is because out of fear of coronavirus and autoworkers, and the UAW basically forced them to do it. The world lives on a 30-day food supply. So, if you stop food production today, there would only be 30 days of food for the whole world to eat, based on our calorie consumption per day. And especially with an isolated border, and we import a lot of food in the United States. If that means that we are then going to shut down other factories, the Ford-GM shutdown,

• 5:02David Friedberg?

  and we're going to shut down food production, processing, and distribution factories, then we have a food security crisis. And this becomes a real societal problem. So, the concern that I have with the factories being shut down today is the precedent it sets, and the potential follow-on from there in the food system. And one thing we can't stop doing is making and distributing food to humans in the United States, or else we are going to have problems.

• 5:24Chamath Palihapitiya?

  You're right, but before we go there, the good news is that these directives don't apply to national critical infrastructure, and the food supply is covered within that. So, unless something cataclysmic happens, those folks are still going to make sure that food supply is there. I do agree with you that the issue that we have to contend with is that, you know, there may not be as much. And in the, you know, 30th to 90th day, that becomes a real issue, if this thing becomes a very protracted problem. This sort of brings us back, David, without being too alarmist about how we started,

• 6:04Chamath Palihapitiya?

  and how you started, really importantly, at the beginning, which is, there is a small, but very credible body of evidence that is starting to show, and this is what you put out on Twitter, and part of why you got, you know, attacked, probably by the pharma lobby.

• 6:22Chamath Palihapitiya?

  But that shows that there is a, there is potentially an enormously large asymptomatic spreader dynamic in this disease. So can you describe that? And what that may mean and why there is a lot of silver lining and good news in that, if it's true?

• 6:41David Friedberg?

  There are several data points that are showing us that there may be an unexpectedly high number of people that get this disease and don't have any symptoms and show it. The historical data that we've gathered to date has been largely symptomatic patients. And in some places, like in Korea, asymptomatic patients that had really close contact with symptomatic patients that were confirmed to be positive. And in Korea in particular, they found a large cohort, nearly 40% of the infected population were people between 20 and 29 years old that did not exhibit any symptoms or had very mild symptoms, had a runny nose and didn't even know that they were sick. On the Princess cruise ship, it turns out that up to 50% may have been asymptomatic.

• 7:26David Friedberg?

  People were all tested on that cruise ship because there were so many people that were positive. And through that data set, that cohort, we found a very large asymptomatic population, 50% roughly. The NBA players have now been tested and out of seven players on five teams. So out of seven players on those five teams that have tested positive, it seems like none of them are having any symptoms. There may be one person who's having a cough, but generally they seem one of, I think it was Donovan Mitchell said, "I could go play a seven game series tomorrow." So this data is really important. And it hasn't been fully accounted for in the models and the predictions of the pandemic and the predictions of the fatality rate. We're assuming that, let's say, 2% of people that get this disease end up dying. And by the way, that's also based on an age histogram

• 8:10David Friedberg?

  that may not be appropriate for our particular cohort in the United States. If you took that data and then you adjusted it based on the fact that a large percentage of people actually don't die, but they end up just being asymptomatic, it really changes the denominator and it skews the results. A paper published showed that in China, up to 86% of people did not realize that they were sick or they were unreported and they had mild symptoms. If you take that high level, you take that low level, call it somewhere between 25 and 86%, maybe even as high as 86% of patients are asymptomatic, which means that the actual fatality rate is much, much lower even in a large cohort that gets infected here. So we should be mindful of this new data that's emerging,

• 8:52David Friedberg?

  and we're still racing and acting from a policy basis as if 2% of people, 3% of people, 4% of people that get this are going to die, and that may not actually be true based on what we're seeing in the last week.

• 9:03Chamath Palihapitiya?

  I have a comment and a statement. The comment is, people will say, David, you can't extrapolate from an NBA player who may just be in peak physical fitness, although I think your answer is going to be, it's not clear that the disease is correlated necessarily with physical fitness for unphysical fitness at all. It's just maybe the strain and how your body processes it. But then the question is, doesn't this mean that we need to have broad-based, massive testing, not just of symptomatic populations? So not just the PCR test that we've heard a lot about, but also these antibody tests so that we know that people have had it?

• 9:44Jason Calacanis?

  And what's the status of that, David? What's the status of it?

• 9:47David Friedberg?

  That's exactly right, Timon. And by the way, on the healthy NBA player point, it's absolutely true. People that are between 20 and 30, the average age in the NBA is 26 years old. People that are between 20 and 30 years old generally seem to have no to mild symptoms based on what we saw in Korea. The other data sets need to be taken into account. So the NBA is an interesting anecdote, sure. And you could discredit it all you want and say that it's a highly correlated class and so on because everyone's together all the time. But we could look at the data that came out of China in a paper that was published in the journal Science and a paper that was published in the journal Nature from Korea that showed very large percentages, anywhere from 20 to 50 to 80% or 90% of people being completely asymptomatic across an age spectrum.

• 10:29David Friedberg?

  Certainly very heavier weighted towards the younger age bracket. From, you know, children all the way up to 30 or 40 years old, you can be completely asymptomatic. And so these are really interesting discoveries that have happened. And so to your point, we need more data and we need to confirm that hypothesis because that's how science works. So we have a hypothesis, let's go test it. The problem is we're not testing it and we should be as a priority right now because the policy decisions we're making are based upon a denominator that may be wrong. So the correct action should be to go get those antibody tests, go out into the population and start testing the asymptomatic general population and see what percentage of people in these high-risk zones like Seattle and LA and New York and SF already have the antibodies

• 11:12David Friedberg?

  to this virus, meaning they've been infected with this virus and have not or are not showing any symptoms. And that gives us a better sense of A, how widespread this infection is, and B, the true dynamics of the fatality rate and the symptomology of this disease and how it may affect people. Those IGG tests are being made en masse in China today. They're being shipped to countries like Italy where they are in fact being used on the front line. They involve a blood draw and then they have this lateral, they're called a lateral flow assay in terms of how they're kind of tested, the blood runs across a strip and you see a value and you have a pretty good sense at that point. Those kits cost a couple of pennies to make in China. We could probably get a couple million of them. I don't understand why we're not.

• 11:54David Friedberg?

  I don't understand why someone in the federal government isn't begging China and apologizing and appeasing to them to send us those kits. There are a lot of people I know that have bought them on the internet. I have a bunch of them, people that I know have bought them. They have been shipped in through brokers and they are not FDA approved. They cannot be used for diagnostic purposes because of FDA guidelines and how the FDA regulates these things. They can be used for research purposes, but they may not be very sensitive and very specific and they don't have great testing on them. So we don't, they estimate the sensitivity and the specificity to be 90%, roughly 10% false positive, roughly 10% false negative. But for what we're trying to accomplish, that's good enough. We're not trying to give people a diagnosis of disease. We're trying to run an epidemiological study and we should, on the general population

• 12:36David Friedberg?

  to figure out how many people out there are asymptomatic and have been infected. That is an important statistic that's missing.

• 12:42Chamath Palihapitiya?

  And to your point, if we find out that there is a large population of people that have actually felt this disease pass through them, it's faster that we can sort of get people back to work out in the streets, which is now probably going to be the most important thing we can do to just prevent a complete economic calamity.

• 13:04David Friedberg?

  Yeah.

• 13:06Chamath Palihapitiya?

  There are, there are, Jason.

• 13:10David Friedberg?

  And by the way, and sorry, treatments, Chima, sorry to interrupt you, but treatments are the other thing, and I think you're going to talk about that.

• 13:15Chamath Palihapitiya?

  Well, treatments are interesting. Let's talk about that right now, because to me, what's incredible is, again, now what is emerging, and it's small in scale relative to how amplified it may, may should or should not be, is, you know, remdesivir is very different, but it just seems like prophylactically even, there's some data that's showing out of France that chlorquin seems to be effective. These are, these are solutions that are pennies to make. And some of the, some of the feedback that I've heard is that part of why the FDA, the CDC, the, the federal apparatus is reluctant to embrace these things is in part because

• 13:53Chamath Palihapitiya?

  of pressure from those lobbies. But that seems to me unfathomable in a moment like this. So why do you think the government hasn't put out, the CDC has zero directive right now on the management and efficacious management of this disease? Why is that?

• 14:11David Friedberg?

  Okay, what Fauci and others have said, and doctors around the country echo, is that these treatments have not been clinically tested through a blinded controlled study. And that is a very fair assertion, generally speaking, for doing good medicine. But we are in a crisis state. And in a crisis state, you have to triage, and you also have to triage policy. And we should be considering triaging policy and changing the way that we do policy under these extenuating circumstances. If doing treatment can reduce fatality rates by up to 4X, as Korean doctors have claimed, it is worth taking the risk, or perhaps it is worth letting the FDA say remdesivir, calatra, chloroquine, and others are being widely

• 14:56David Friedberg?

  produced, widely distributed, the government is mandating it, and doctors and their patients can decide if and when they want to use it. And let them take the risk without clinical trials and without data and the typical process of the FDA.

• 15:08Jason Calacanis?

  What's the downside of taking these drugs? Are they particularly dangerous? I mean, I've heard the colloquin, am I pronouncing correctly? Choloquin? Chloroquin? I've heard that this can be a little bit nasty in terms of side effects. So is there some major downside that? I mean, it's kind of like an off use of a drug, right? Like this is an off use of a drug as opposed to?

• 15:27David Friedberg?

  It's an off use of a drug and some of the antivirals aren't even fully tested in humans. So we don't yet know what the side effects may be. And also remember, side effects can change based upon your health condition. So someone that's in respiratory distress may have different side effects than someone who's taking it in a healthy, controlled clinical trial. So we're not really sure. That's the argument that doctors would make is, you know, our first mandate is to do no harm. And so they don't want to apply a medicine that might do harm. And so that is the standard protocol and practice and process. However, again, in a crisis state, China and Korea said, guys, we're trying this thing and it's working and we're adopting it. Let's go for it. And they raced forward. It could be that this is a good time for the United States to consider an emergency

• 16:10David Friedberg?

  policy action where we make a lot of this stuff, make it available and simply let doctors use their best judgment rather than have the FDA be the paternal state that makes a decision for the doctors or makes a recommendation to the doctors.

• 16:23Jason Calacanis?

  What do we think the fatality rate actually is? Like David, if you were looking at this and you had to place a bet and put 100% of your net worth on it and be all in and have massive skin in the game, where do you think the fatality rate here in the United States winds up being overall? Because the data that came out of Wuhan has been markedly going down as they get the numbers corrected. Who knows Chinese numbers, you know, censored by the government and maybe perhaps massaged. It's going to be hard to tell. What do you think the real fatality rate is? The first fatality rate I heard was 5.8% out of China.

• 17:01David Friedberg?

  The Wuhan data, the Wu, the Wu, based on the paper that came out in Science over the weekend, the Wuhan data was estimated to be 1.4%, and Wuhan was the worst data out of China. The quote-unquote "rest of China" is still estimated at about 0.15%, or 0.16%, or 0.14%, something like that.

• 17:18Jason Calacanis?

  Where is that versus, like, the flu every year or something, or the normal flu?

• 17:22David Friedberg?

  1.1% roughly. And so, you know, if you're looking at somewhere between 0.2 and 1.5%, now, in Italy, I think they're at over 7%. We talked about this on the last show, but Italy is a much older population, and their health system is completely overwhelmed. So, there's some confounding data, there's confounding variables there that may be making Italy a very unique outlier on a distribution of what's gonna happen here. The United States has a population that's a little bit older than China, but much younger than Italy. So, our health system is, and our health system is generally more ICU beds per capita than Italy, so we should be in a better place. The thing we don't know that does concern me about the health system in the United States, and the population of the United

• 18:04David Friedberg?

  States, is it seems that there may be a high correlation with severity of disease and A1C levels. And, as a result, the US has one of the highest obesity rates of any country in the world, and highest diabetes rates. And so, we may have a population that has a very high percentage of people with a high A1C, that may be at higher risk than, say, people in other countries. I don't know that for sure, but that is, those are two kind of confounding statistics that may kind of make things a little bit worse. If I were to put my money on this, look, I'm a betting guy, I would be a little bit nervous at this point, but I'd say it's probably somewhere between 0.15 and, and call it 1.8%, you know, that's, that's an order of magnitude, I know, so, you know, but you could do the math, that's

• 18:49David Friedberg?

  probably somewhere between 1 and 10 times as bad as the flu. And so, that, that, again, leads to the big policy question about are the actions warranted, is it okay to let the health system crash?

• 19:00Jason Calacanis?

  So, that's a perfect, then, flip to you, Chamath. You've heard his, basically, his line at, you know, 0.1 to 10 times the flu, 1.8 or something. You know, if we split the difference of those two, it's 0.5, it's 0.6, 0.7, fatality rate, is the reaction of sheltering in place and the economic turmoil it's causing worth it? Yes or no?

• 19:25Chamath Palihapitiya?

  Right now, you guys need to keep talking. I need to jump off for two seconds and I'm gonna be right back. I'll be right back.

• 19:31Jason Calacanis?

  Okay, no problem. And so, what do you, what do you think now if we were to look at your estimate, David? Is it actually worth what's happening? Would we, if you and I were making the policy, or you and I and Chamath were, you know, the cabinet members, as it were, making this decision, is this decision and the economy crashing in a potentiality of 10, 15, 20% unemployment and all the downstream effects, would it be better to do what the UK was originally doing, which is just say, hey, let's get the herd mentality going, and let's get the herd immunity going? I know this is like, the most difficult question in the world, but we're here, so let's...

• 20:06David Friedberg?

  Look, there's a spectrum of options. It's not binary, right? It may not be lock everyone up and let everyone out the door. It may be that you have a more nuanced policy where you say, let's keep people over 65 years old, give them the strong recommendation to stay home, and make sure that you distribute chloroquine to doctors around the country. So as soon as elderly people start having symptoms, they maybe get some treatment. But, you know, that's kind of an option. You keep 65-year-olds at home, you do random, general population antibody testing, and once you hit a certain percentage of the population having been exposed to this thing, it may be that at that point, you say, okay, you know, the over 65 limit is lifted, or it may be that, you know, you do something similar

• 20:50David Friedberg?

  to that. Different age brackets have different containment recommendations. You also do it with, with random gen pop screening. You also do it with medicine being distributed. So there's a nuanced answer to that, where the policy should be a little bit more directed. It should be a little bit more involved in terms of treatment, testing, and containment strategy, and it doesn't need to be so binary.

• 21:12Jason Calacanis?

  Right. It doesn't have to be everybody stay at home. If we get to the point where a population has very few people have had it, then more people should stay home so it doesn't spread? Or, and then if more people have it, so if 50% of young people in San Francisco have it already, we've got herd immunity, then maybe we can start saying, hey, if you're over 65, you can go out. But just stay out of restaurants or something. Is that what you're saying?

• 21:37David Friedberg?

  Yeah, once you hit like fifty to sixty percent of the population having antibodies to a particular virus, you, you know, or like a flu, for example, you'll see that R naught number drop well below one.

• 21:48Jason Calacanis?

  Explain R naught to everybody again, just so.

• 21:51David Friedberg?

  Yeah, it's basically like the viral coefficient, like for every one person that's infected, R naught tells you how many other people will get infected after them. And so if it's two point five, which is what some estimates say it is for coronavirus right now, then for every one person that gets infected, roughly two and a half people get infected. And that number goes down as more people get infected because as more people get infected, there's less people to infect and the rate at which you can then infect other people also drops. So your R naught collapses. And so at a certain point, you have this kind of basis for saying, hey, guys, let's, um, okay, now I gotta step off. Sorry, guys.

• 22:25Jason Calacanis?

  You have a problem, do you think? So Shama, what David was just explaining.

• 22:28Chamath Palihapitiya?

  I mean, what you are seeing in real time as we're doing this is literally like, I've, I've never seen this before.

• 22:37Chamath Palihapitiya?

  We, we should probably explain what, uh, what is going on. So what is going on in the background is, um, the markets are just completely torn. Now, why are the markets important? Many people aren't invested at all in the stock market. I get it. But it is where liquidity and capital markets function and derived out of those capital markets is the money that then hits startups, it hits the banks, which then lend to small businesses. It is the functional, uh, machine, the undergirding of the US and the world economy. And, uh, we are in a moment that I have really not seen since oh eight,

• 23:21Chamath Palihapitiya?

  where, uh, there are seizures, uh, in this market in, uh, extremely violent ways. Uh, and so when I had to jump off the phone, it was me, uh, trying to do my part to kind of help, but also trying to, uh, make sure that, you know, we maintain, uh, full liquidity in times like. This it's incredible. Now, Jason, on the assumption that, you know, Friedberg may or may not come back. I mean, what dramatic podcasting we're dealing with.

• 23:53Jason Calacanis?

  I know. Well, you know, I mean, people also have their kids at home. So, you know, I might have to jump out and take care of the twins or my 10 year old. So it is definitely having a psychological impact on everybody being home. You've been home for over two weeks. I've been home for a week. I went out once to do a podcast at my office with just one person there.

• 24:11Chamath Palihapitiya?

  What I wanted to do was start at sort of the 10 foot level. And I'd like to build up to the 100,000 foot level. And I think that'll be a good way of talking about what we teased and talked about a little bit in episode zero, which is sort of these second and third order dynamics.

• 24:33Jason Calacanis?

  Before we go to that, let me just, I want to wrap up with Dave would saying about what the change in policy should or could be. So right now we have, we're having, you know, this basically quarantine. In some cases, it's a hard quarantine. In some cases, a little bit softer. It's a recommendation and, you know, people are being told to, you know, stay at home. Should this change? And if, under what conditions do we start going back to normalcy? Because I think that's what people want to know is when is this going to end? And under what circumstances? I'm just talking about, you know, staying home.

• 25:09Chamath Palihapitiya?

  Well, look, if it were me, I think what we would do is adopt some of the mitigation strategies of China and Korea and Singapore. All of these countries have kind of showed us a way to deal with it now. We have to decide that a short term suspension of typical civil liberties is worth the trade off. Now, it's not worth it under the normal course, under any, any, any imaginable way. But if we had to trade off some of those civil liberties in the short course so that we could get back to normalcy, I think most of us at this point, and definitely all of us after another week or two of home isolation, will do it. And what I think it would entail.

• 25:55Chamath Palihapitiya?

  Is setting up zones that we would understand to be uninfected. And what that means are people that don't have it or people that have antibodies. And eventually allowing those zones to reopen so that we can actually have some amount of economic activity. And what that will require is massive testing of the entire population.

• 26:18Jason Calacanis?

  Right.

• 26:18Chamath Palihapitiya?

  Testing, testing, testing. I mean, there should be lines and lines and lines. It should be, you know, how we would have, and we know, by the way, how to mobilize this. It is no different than when we would go to vote.

• 26:31Jason Calacanis?

  Right.

• 26:32Chamath Palihapitiya?

  And, you know, we could all be told, based on birth year, right? Everybody go based on birth year to your local voting facility. There are phlebotomists there, they can run these LFIAs, they can, and they can, they can allow you to be in a safe zone or not a safe zone. If you're found to be an asymptomatic carrier, then you can self-quarantine and socially distance. And we can really, you know, nip this thing in the bud in a, you know, four, five, six week timeframe.

• 27:01Jason Calacanis?

  Yeah.

• 27:02Chamath Palihapitiya?

  Because these tests are available at such large scale and because these tests are so insignificantly cheap.

• 27:10Chamath Palihapitiya?

  If it, if it were up to me, I would mobilize the military and the National Guard. I would mobilize our voting infrastructure.

• 27:17Jason Calacanis?

  I mean, another way to do this would be, why don't we just have the National Guard or doctors or whatever? Just go to everybody's mailbox, put in the kits and then say, you know, have your kit in here on this date and we'll go pick up the kits.

• 27:28Chamath Palihapitiya?

  The problem with these LFIAs is that the amount of blood that you need, you cannot draw by yourself. It's not a finger.

• 27:34Jason Calacanis?

  What about the swab stuff? I mean, if we just did the swab testing, we just said, hey, we're coming by your house.

• 27:39Chamath Palihapitiya?

  The swab is a PCR test that's looking for RNA. And the problem with that is that it's effective in a window. It's uncomfortable to administer and it has to be done right away for those that are in the process of viral shedding.

• 27:51Jason Calacanis?

  Got it.

• 27:52Chamath Palihapitiya?

  If you are not in the process of viral shedding, then that PCR test is effectively ineffective. And what I'm advocating for is move past the PCR testing. That should be done in an acute situation if you come into a hospital where you're exhibiting symptoms. The more important thing right now is to find people that don't have it or people who are asymptomatic spreading or those people that are immune. Because if we can re-baseline the denominator, as Friedberg said, we may find some good news in that it's very much like the flu in terms of numerical distribution, in which case we can make some policy changes and re-establish economic activity. If it turns out that it's not, at least we know that too. But right now, we're in the worst place, which is that we are in a situation of isolation

• 28:37Chamath Palihapitiya?

  and confinement in the absence of data. And this is, I think, what's so infuriating to folks is that we, you know, it's like Winston Churchill said, "America will do the right thing, it's just that they'll try everything else first." And I think that we are clearly on that path to trying everything until we do the right thing.

• 28:58Jason Calacanis?

  Everything okay?

• 28:59Chamath Palihapitiya?

  And I think it's political poker, is the reason why.

• 29:03Jason Calacanis?

  Friedberg, everything okay?

• 29:06David Friedberg?

  Just market trades.

• 29:09Jason Calacanis?

  Really? It's like literally, you're trying to cover stuff and just...

• 29:13David Friedberg?

  I'll tell you, it's a great time to tax harvest losses, man.

• 29:19Jason Calacanis?

  Yeah.

• 29:19David Friedberg?

  If you've got companies that you're really religious about, that you would love to own for a long time and you're underwater on them, it's a great time to sell them, take the loss, harvest it, and then buy them back in the next 30 days.

• 29:30Chamath Palihapitiya?

  So, David, I have a list of eight things. And what I told Jason is I wanted to start at the 10-foot level and end at the 100,000-foot level, okay? And so I'm going to tee up the first question for both of you guys, and I have a view, but I'll save it to the end. So, question number one of these eight lists of interesting things to talk about, which may be relevant for the folks listening. What does this mean for startups? And what should you do if you are a unprofitable? Well, I mean, by definition, these companies are default dead. What do you do if you're a startup CEO today?

• 30:09Jason Calacanis?

  Yeah, I think it's a great question. I'm dealing with it like with about a dozen companies a day who are in this very acute situation. You have to figure out, you have to look at the instrument panel and then try to, like a pilot, I use the analogy, understand exactly how much altitude you have, where the nearest airport is, how much fuel you've got on board. So I've literally told folks, listen, if you can close this money, because a lot of people were in the middle of doing deals, close it immediately. So that's number one. If you've got a deal on the table, take the money. And some people do, but most people don't. And I'm already seeing people re-trading deal terms based and backing out. So I had one person back out of a deal on the syndicate.com. An angel investor said, because of market conditions, I'm backing out. And they had made the commitment, they're backing out.

• 30:54Jason Calacanis?

  So you're going to see commitment's broken. So assume it's going to, that no money's going to get raised for the next three or six months at a minimum. And then you have to ask yourself, well, how do I keep this company alive? I have people who are founders taking 80% salary cuts and then giving their staff 50% salary cuts. And then that takes their six months of runway and makes it nine. So that's number one. You have to just make the cuts. And if you've chosen to be the founder of the company, that's your job is to get everybody to safety. And better to have four out of five or three out of five employees lose their job and the company be alive to come back and maybe get some stimulus later than to have the company go out of business because you wouldn't make the cuts. So you've got to just take the medicine. And that's really with first time entrepreneurs, they don't understand that.

• 31:38Jason Calacanis?

  And if they have, and every business is different. We have some companies that are subscription based business or delivery based businesses. They're actually seeing an increase in utilization, increase of people trialing their software. So I have one company that's a consumer subscription. They had more trials this week than ever because people have free time. So that company's going to be fine, but you've got to make the cuts. David, I'm not sure what your advice is or what you're doing in your portfolio.

• 32:02David Friedberg?

  Yeah, I mean, look, I'm on 12 boards. Four companies have been or are in the middle of term sheet or closing a deal. So it's been an unfortunate timing for all this stuff.

• 32:13David Friedberg?

  What happens to those four companies? Do you think they close the term sheets? Yeah, very different things. I mean, we've got one that I hope we close on Friday. We signed on Friday, last Friday, the final docs and money's not in the bank account yet. I've got another one that's had a bunch of offers that got rescinded, but they weren't like signed yet. It's just all over the place. And I think, you know, one thing that's, that's worth kind of paying attention to for every company is you've got to ask yourself firstly, the hard question of going into this and coming out of this era that we're kind of now entering, that is a very bleak and dark era economically. Where's your customer going to be and what is your customer going to be doing? The customer model is changing overnight.

• 32:59David Friedberg?

  If you're a company that, that sold, you know, software into restaurants and restaurants are about to potentially go bankrupt or suffer absolutely loss of revenue and get, you know, debt payments restructured. They're not going to necessarily be rushing to spend more money each month unless you can help them immediately save money. If you're a company selling to consumers and you're selling to consumers that are going to lose their jobs in the next three months or lending to consumers, they're going to be losing their jobs in the next three months. You've got to be asking yourself the question, what can I be doing with my business? So you got to start with your strategy question and you got to make sure that your customer, you got to think about where your customer is going to be and how you can adjust your strategy as a result.

• 33:40David Friedberg?

  The second thing I'd say is, and I sent out a note to my CEOs and I was like, guys, you gotta, you know, cut your burn and then you gotta cut your burn and then you gotta cut your burn if you've got burn. You gotta do everything you can to give yourself the greatest chance of survival. And I think on the last all in podcast, Jason, you mentioned having a, you know, 36 months of cash. That's ideal, but if you can get your cash back, your cash to get you to an 18 month runway. Yeah, 18 is my average. Yeah, I mean, you should be, you should be doing everything you can to number one, kind of. Give yourself that breathing room, even if that means trading milestones, trading features, trading revenue goals, trading all the things that you're expecting to do.

• 34:20David Friedberg?

  Survival matters more than growth right now. David Sinclair, who wrote the book Lifespan and is a Harvard biochemist, has highlighted that there's basically a gene, the CertD genes, there's about seven of them in humans, and the CertD genes get turned on or off. And it turns out every biological organism on planet Earth has a CertD gene. The CertD gene tells the organism or tells the cell to either grow or heal. And this is a time for everyone to activate their CertD genes and stop focusing on growth and focus on healing. It's really important to optimize your unit economics, to make sure you know where your customer is, to really reduce the burn, to reduce the spend, to reduce the push for growth and expansion, and just make sure you've got a core business, that you have a customer,

• 35:03David Friedberg?

  that you can make money from that customer, that you've really got unit economics right, and reduce your burn and give yourself that runway and extend your life. So that's my kind of advice.

• 35:13Jason Calacanis?

  Well, I think we got question one out of the way.

• 35:15Chamath Palihapitiya?

  Let me, let me give you my, my advice, which is building on the back of both of what you said, but I'm going to take it from a different perspective. So let's look inside of a VC firm. VC firms have limited partners, and those limited partners are the most sophisticated financial institutions in the world. Family offices of well-renowned individuals, foundations, university endowments, nonprofits, you name it. And all of them are allowed to invest in this asset class because they themselves can prove that they're sophisticated. And one way in which they do it is they, they have what's called portfolio allocation theory.

• 36:00Chamath Palihapitiya?

  They construct a portfolio of every hundred dollars they have, and they say, well, I'd like to have, you know, 70% of that in liquid instruments, and that I'm going to have 60% in bonds and, you know, 40% in equities. And then that 30% they'll take and they'll say, you know, I want to have a mixture of all kinds of different stuff, some real estate, some hedge funds, some private equity. And eventually, when all of those allocations are done, there's an allocation to venture. Now, in the last few years, what happened is all of these folks, you know, moved the dial, they pushed the risk meter, so that the allocation into venture was upwards of 7, 8, 9% of their overall portfolio.

• 36:45Chamath Palihapitiya?

  Now, just to remind you guys, you know, basic theory, monetary theory would tell you, when you put money in into an illiquid instrument, remember, venture doesn't return money until 13 years after it's done and you can't get it out. It's not like a bond where you can go and instantaneously sell it in a second. You have to get returns that are much better than the market, because you need to be rewarded, paid back for that illiquidity.

• 37:12Chamath Palihapitiya?

  Now, in the last month, what you've seen are portfolios get completely turned upside down. If your bonds and equities before were worth $60 or $70 of that 100, it's now worth $56. It could be worth $40. What that means is that that other $30 needs to be worth much, much less, otherwise your portfolio model is completely upside down and all of these limited partners become forced sellers as well. So that can't happen.

• 37:48Jason Calacanis?

  So what is the, my understanding is, the last time this happened, in 2008, LPs kind of winked to the GPs and said, "Listen, it would be good if there wasn't a capital call right now." And then, GPs not wanting to piss off their LPs, the VC firms not wanting to piss off the endowments as an example, said, "Okay, we're just gonna not make any capital calls right now while the market recovers so that your equities go up and the percentage of venture goes back down." Is that, is that the likely scenario? Is LPs...

• 38:20Chamath Palihapitiya?

  It's worse than that. It's worse than that, because right now, these foundations and sovereign wealth funds are trying to just stay above water. And as we get to the 10,000 and 100,000 foot view, I'll give you the picture of what's happening in their offices. And again, it's important, because it is what makes sure we come out of this reasonably well, which is a properly functioning capital market. And right now, it is the most precarious that I have seen in 20 years. So basically, these LPs are gonna have to portfolio rebalance, and they're gonna have to force venture capitalists to mark down their books.

• 38:59Jason Calacanis?

  So wait, VCs are just going to make that decision to say, hey, my investment in Airbnb, Slack, or Uber is worth X now. I mean, when they were private companies.

• 39:08Chamath Palihapitiya?

  Not Slack and not Uber because they're public.

• 39:10Jason Calacanis?

  Right, but previously private, yeah.

• 39:13Chamath Palihapitiya?

  But Airbnb, can it be marked at $30 or $40 billion? The auditors will probably say no. The LPs will say that it's not. The GPs will want to because it'll allow them to maintain their IRRs, their rates of return. And so what you're going to have is when these markdowns are forced to happen, which will take another six months, venture capitalists' returns will look terrible. And so their propensity to be able to add "bad dollars after good", quote unquote, you know, to defend every company, is going to go to zero.

• 39:49Jason Calacanis?

  Right.

• 39:49Chamath Palihapitiya?

  And as you said, Jason, there's going to be a pall on activity. So I don't think 18 months is sufficient. I think you need at least 36 months.

• 40:00Jason Calacanis?

  Double. You need to have three years of capital in the bank.

• 40:04Chamath Palihapitiya?

  The worst thing that'll happen if you have 36 months is you think to yourself, wow, I was really conservative. The best thing that happens with 36 months is you survive. The distribution of outcomes would tell you, there is zero point in taking the risk if you don't have to. And this is why, unfortunately, it's going to be a very difficult process of recalibrating all of this stuff. So for folks that are in these startups,

• 40:33Chamath Palihapitiya?

  we're going to have to go through an unfortunate period of pain. And, you know, as Buffett said, you know, rule number one of our business is to not go out of business. Rule number two is not to forget rule number one.

• 40:45Jason Calacanis?

  Yeah. All right. I think it's well said. And is there any chance?

• 40:53Jason Calacanis?

  While we're sort of at this, you know, street level on the front lines, is there any chance that we contain this very quickly, let's say, under 60 days? And that it looks like this virus mitigation through the various drugs we talked about actually starts to work? If that happens in the next 60 days, what will happen to the markets?

• 41:17Chamath Palihapitiya?

  It's not what we're dealing with.

• 41:19Jason Calacanis?

  But Trump says it's gonna come, there's a chance it could come roaring back. What are the chances of a roar back?

• 41:24Chamath Palihapitiya?

  It cannot come roaring back. So let me explain to you what's happening right now in the capital markets. So let's take a step back and first look at what the Fed has announced over the last couple of days. So, and here's why the Federal Reserve is important. So the Fed basically acts as a market making and liquidity function in what's called the overnight repo market. Now, that's an obscure market for the average individual on Main Street, but let me roughly explain why it exists. And at the end of it, you're probably gonna have the same reaction as me, which is, what the fuck, fucking, what the fucking fuck? Okay, but I'll explain it in English first.

• 42:05Chamath Palihapitiya?

  You're an LP, a limited partner, and you give a hedge fund a dollar. And very much like last episode, how I explained why hedge funds run levered. The hedge fund says, well, if I take this dollar, you know, the bank will give me some amount of leverage on it. But it would be much better if I was able to basically, you know, give them an instrument like a bond or some sort of short-term commercial paper. And then they'll give me more because they'll believe in the quality of the instrument. Okay, so they go on the repo market and they basically do a transaction overnight where they basically, you know, buy some short-term commercial paper. They use it as collateral and then they lever it up and then they go put it in the market.

• 42:48Chamath Palihapitiya?

  That entire dynamic works as long as the repo function works every day. Every night, you kind of go and you clean up your balance sheet. You look at how much leverage you have. You look at your leverage ratio. You make sure that you have enough money. And you go and you refinance your short-term paper that keeps, you know, JP Morgan, Goldman Sachs, Morgan Stanley lending to you. But if that market seizes, when the repo market seizes and there's no way for you to either buy or sell commercial paper, buy or sell short-term money market instruments. And on the other side... The markets are whipsawing up and down and so you're being margin called, not being margin called, being margin called, not being margin called.

• 43:29Chamath Palihapitiya?

  The markets start to really seize and capitulate and everybody is just losing enormous amounts of money. And what I mean by everybody, it's everybody. It's hedge funds, it's sovereign wealth funds, it's foundations, it's central banks. Everybody is losing money. And if we don't figure out how to bring some calm into the financial markets, it will leave all of these limited partners and all of these other people with not just a lack of liquidity and a lot less money than they had before, but this psychological pain of remembering what they just went through.

• 44:11Chamath Palihapitiya?

  And that'll prolong what we have to deal with to get out of it, right? So, you know, this is why I think it's really important to understand that if we can nip the, you know, stage zero of this problem, which is the disease itself in the bud, and I don't mean by curing it, and I don't mean with a vaccine, I mean by testing and data.

• 44:35Jason Calacanis?

  Yeah.

• 44:36Chamath Palihapitiya?

  If we can understand and bound it, then everybody's psychology can move to fixing the capital markets.

• 44:41Jason Calacanis?

  How close are we to that, David?

• 44:43Chamath Palihapitiya?

  And right now, we need it to be fixed.

• 44:45Jason Calacanis?

  How close do you think we are to having that mass testing done? And then I think we all think we're going to have a low mortality rate and then go back to normalcy. Is that something that's happening in 10 days, 30 days, or 60 days, if you had to pick a number? The march back to normality. David?

• 45:03David Friedberg?

  I don't see any action to get the testing done that needs to get done right now.

• 45:09Jason Calacanis?

  My mom got tested yesterday. It seems like there are more tests out there this week than previously. Stanford opened up the testing.

• 45:15David Friedberg?

  There's definitely PCR testing available now and you can probably get your results in three to four days on average, although some labs are super backed up.

• 45:23Jason Calacanis?

  Yeah, my mom said she's gonna take three days or four days.

• 45:25David Friedberg?

  Three days, yeah. But the stuff that we're talking about, which is the general population testing, I'll keep saying it, it's so critical that we do this to figure out how many people have already been infected and didn't know it. We don't have that data that we don't even have a plan for, and it's not on the radar. The task force in DC is focused right now on increasing the throughput and the availability of PCR or just-in-time, you know, PCR testing.

• 45:48Jason Calacanis?

  The blood testing, that's a good one.

• 45:51David Friedberg?

  Yeah, it's all blood testing. It's just a matter of like, like, let me explain the PCR test involved, the RT-PCR test involves taking blood, and then there's basically six steps that you have to go through with it in a lab. And it's done on like three different machines, and the actual cycle takes 30 to 60 minutes, or 30 to 45 minutes. So by the time you have that backlog, and you can multiplex it, but, meaning you can do multiple at the same time, and you can kind of do different things, but generally, these machines are not highly automated. There are new machines that are allowing us to automate more of these steps and making them go a little bit faster and do more multiplexing, but it is still a multi-step cycle to take the blood and turn it into a test result once you've amplified the viral RNA and tried to measure its content.

• 46:37David Friedberg?

  And so this takes some time, and so it's a chemistry lab that's doing this work. So until we have a point-of-care solution, which is like a test strip or something else, and these are technically possible, it's just that they're not FDA-approved, and so they're not getting made and distributed here, whereas China and Korea and Italy are using them, and they're made in factories in China, even though they're not tested and approved in the normal way.

• 47:01Jason Calacanis?

  Isn't the plan, though, to have these untested tests online this week? Isn't that what they're saying?

• 47:05David Friedberg?

  Yeah, a bunch of people are buying them.

• 47:07Jason Calacanis?

  Yeah, but, so I guess the question is, when do you think we will have these, you know, the general population taking tests, and we get like a large-scale testing like South Korea did? We all agree that's the part of the solution. When does that happen?

• 47:24David Friedberg?

  Unfortunately, we're not parallel-pathing it. We've put all of our resources into increasing the availability and throughput of the RT-PCR tests for acute infection cases. And as a result, we have everyone focused on this. There was some lab work and some research departments, I won't name them, that were working on doing this general population testing, but they got yanked into the getting the RT-PCR scaled up because, "Oh, my God, we're behind the curve. We've got to fix this thing." So, we've got to get over this first hump. I think, once we get over this first hump, then you're going to see people distribute and work on this. And I think getting over the first hump is happening in the next, call it, seven to 10 days. And so, then it's probably another 30 to 45 days before we get these tests, for general population tests, staying more broadly distributed. So, call it 45 days out.

• 48:07Jason Calacanis?

  Why can't we do this at the same time? I mean, why can't we parallel this? This makes no sense to me. We're the greatest country in the world.

• 48:13David Friedberg?

  Totally. And we have so many scientists and so many entrepreneurs in Silicon Valley that are banging their head on the wall, asking this question. I've done so many phone calls over the last few days of people being like, "What can we do? How can we get these things made? Where can we go?" And everyone's just, like, flustered. It's really frustrating. Anyway, we've got a lot of individuals that we're trying to kind of collect together to do this work. Some folks are calling China today. We're trying to see if we can get big bulk orders out of China. We're just going to pay for it ourselves and then try and get some research labs to run the, you know, research universities around the country to run the experiments for us, using these untested, unproven, you know, not FDA-approved tests.

• 48:46Jason Calacanis?

  Have you run one of these on yourself yet? One of these unproven tests yet?

• 48:49David Friedberg?

  I haven't. I actually, a friend of ours, I did one with video on, with him this morning. And so, you know, someone that we all know.

• 48:56Jason Calacanis?

  A mutual friend of ours?

• 48:57David Friedberg?

  A mutual friend of ours, yeah. And so, and then I know lots of people that have them and have used them. And I've seen them and I've gone through, like, you know, I bought a bunch of them. They arrive tomorrow. And so, I see, you know, we see, we know how these things work. They're actually from a reliable source. You know, these are not, no one's actually done the testing to prove the specificity and sensitivity. We're relying on a third-party, you know, test. We don't really know, but any data is better than no data.

• 49:22Jason Calacanis?

  I keep hearing they're uncomfortable. What's uncomfortable with them? They stick it very far up your nose? Is that what people are referring to?

• 49:27David Friedberg?

  Oh, no. You're referring to the RT-PCR test. So, what you're trying to do there is you're trying to get a Sample of living virus on a swab. And the best place to get that living virus for this particular virus is in your nose or in your the back of your throat. So they're taking a long Q tip and they're sticking it up your nose or they're sticking it back your throat. Then they put it in a little solution that will keep the viral RNA alive. And then that's what they're shipping to the lab and that's what then gets.

• 49:48Jason Calacanis?

  So it's uncomfortable to have it that far up your nose is what they're saying. That's why people keep saying it's uncomfortable.

• 49:53David Friedberg?

  I've had more uncomfortable things up my nose. I'm sure it's fine, you know.

• 49:56Jason Calacanis?

  Yeah.

• 49:58David Friedberg?

  You know, it's a it's a Q it's a Q tip in your nose. Yeah.

• 50:00Jason Calacanis?

  Yeah, it's a Q tip way up in your nose.

• 50:02David Friedberg?

  Okay, up in your nose.

• 50:03Jason Calacanis?

  So we actually think that mass testing is a 30 to 60 day.

• 50:08Chamath Palihapitiya?

  I think it mass testing if if in the worst cases 30 is 30 to 60 days. What I'm imploring anybody with any influence is we need to get this starting to happen in the next two to three weeks.

• 50:23Chamath Palihapitiya?

  It needs to start happening in the next two to three weeks. And, you know, this is this is where I would say there are a lot of other people other than David, myself, you, Jason, the people on our group chat. Buying tests for the mass population. You know, I just I just want to say something here, which is it is incredible to see guys like Jack Ma. Step up and, you know, do what he can to send stuff here. But I would say that thus far there's largely been an inverse correlation of contribution. And wealth during all of this and folks that are in a position to help. I think need to be more vocal, you know, we all can't just participate when the times are good. Take advantage of the bully pulpit when the times are good.

• 51:08Chamath Palihapitiya?

  And then when times are complicated disappear and become anonymous. It's part in why I think you and I decided to just do these as often as we can.

• 51:16Jason Calacanis?

  Yeah.

• 51:16Chamath Palihapitiya?

  Because at least we can think through the problem so that at least people can hear our voices and understand that we are thinking through as much as possible what to do. I am literally calling folks in Wall Street all the time because what little I can do to assure them or be a market participant right now to maintain liquidity. I need to do because in the absence of that participation, we're going to just create more and more havoc. And I think it's important for other people. Who are in a position, either monetarily or through influence or both, to be out there right now, doing something. You know, they should call Friedberg right now. They should give Friedberg $100 billion. We'll go to China, we'll get the tests, and we can do our broad-based population study right now.

• 52:01David Friedberg?

  Yeah, I would, I would jump on that.

• 52:03Jason Calacanis?

  Uh, right now, looking at the statistics as of today, um, we, uh, obviously, the total cases in China hit 80,000 with 3,237 deaths. They had only 11 new deaths yesterday. Um, and Italy, uh, 35,000 total cases, 4,200 new cases, and they added 475 deaths yesterday, um, with a total death count of 2,978. So that is just stunning what's happening in Italy. And it seems, I don't know if the trend line is it's getting worse or not. Um, but, uh,

• 52:40David Friedberg?

  Italy, Italy gets overwhelmed. It's, it's, it's a, it's a horrific and awful situation. They're completely out of beds. They're, they're triaging, uh, elderly people and letting them die in the hall so that younger people who have a higher chance of surviving can actually get oxygen. It's just awful.

• 52:56Jason Calacanis?

  And they're having 3,500 new cases, or they're at 3,500. Yeah, they're, they're over 3,000 cases, uh, but, uh, added yesterday. So there's really, it's, it is flattening, but who knows if that's because they're just overwhelmed and they can't do the testing. Uh, but the deaths are something that seems to have gone down the last three days.

• 53:18David Friedberg?

  We're looking at different time series. The number of people that died yesterday are in fact the number of people that died yesterday. The number of people that tested positive yesterday doesn't tell you as much, because the test results may be four days delayed, and they may be 10 days into their symptoms by the time they get tested, and so on and so forth. So the testing data significantly lags the infected population count, likely, and may, may not represent much of anything, right? So there, it's very, and it's also hard to know what the average fatality timeline looks like. There are published reports now out of China and Korea that start to try and specify this a little bit, but we are looking at different time series when we try and compare these things. Um, and so everyone be cognizant of that. As you look at these numbers, it's not simple apples and apples.

• 54:00Chamath Palihapitiya?

  Let's move to a slightly second and third order, Jason. I think if we stay in the disease, it's just going to be a fucking mental quagmire. We're going to jump out the window.

• 54:10Jason Calacanis?

  Yeah.

• 54:12Chamath Palihapitiya?

  Okay, let's talk about something that Mark Cuban said, which I really agree with, which is that if we're going to do bailouts, they can't come where we also do things like, you know, allowing these companies to do buybacks where CEO pay isn't curtailed. You know, it turns out that the airline industry, which looks like it's going to be first in line for bailout, spent 96 cents of every single dollar of free cash flow they had on buying back stock, which is only used to drive up earnings per share, which is only relevant for CEO pay. So they have, you know, they don't have the cash buffer. They don't have the 36 months of operating, you know, window that, you know, everybody should have.

• 54:52Jason Calacanis?

  They blew it on trying to hit, they blew it on trying to have their earnings per share go up by reducing the number of shares in existence.

• 54:59Chamath Palihapitiya?

  Shares, exactly.

• 55:00Jason Calacanis?

  Just so people understand.

• 55:01Chamath Palihapitiya?

  If you can't, if you can't, earnings per share, you know, you take earnings, you divide it by the number of shares. So if earnings can't go up, just divide by the number of shares and earnings per share goes up.

• 55:11Jason Calacanis?

  Lower the number of shares. Yeah. If you had a million dollars in earnings, a million shares, it was a dollar per, you get rid of half the shares, it now goes up.

• 55:18Chamath Palihapitiya?

  And so now, you know, you have CEO pay go through the roof, but these companies are not any more resilient than they were before. And so now they're in line for a bailout. And I think the, a large caucus of people across both aisles are very clear that these things need to be wipeouts of the equity versus bailouts where, you know, folks who took advantage of the financial system here continue to get rewarded. What do you guys think about that?

• 55:46David Friedberg?

  Totally agree.

• 55:48Jason Calacanis?

  If you wipe out the equity though, just pausing for a second and taking the other side of the argument, I'm not saying this is the side I would take. If you wipe out the equity, would not some of the people who would hit that pain are shareholders from a retirement home or a retirement plan like CalPERS maybe owns?

• 56:04David Friedberg?

  Pension funds, yeah.

• 56:05Jason Calacanis?

  Pension funds, et cetera. So, you know, it does seem like if you wipe out the equity, you could have some unintended consequences with equity holders. But I think what the other side of the argument is, we're going to have to have there be repercussions for people running companies so close and recklessly to the cliff. And there has to be some pain, not reward, for doing that. And a bailout is a reward for operating irresponsibly. Is that what you're saying, Chamath?

• 56:32Chamath Palihapitiya?

  Yeah, I think that actually you have to wipe out the equity. And I think the reason why wiping out the equity is important is that it overwhelmingly does not punish the retiree in their who owns Boeing stock in their 401K. Boeing has not been held by retirees in their 401Ks for years as a cohort of impactful investors. Massive, large institutional pools of money own these companies. These are the balance sheets of governments. These are the balance sheets of foundations. These are the balance sheets of a very few, very, very wealthy people.

• 57:12Chamath Palihapitiya?

  And the reality is that for the broad-based population, for the 350-odd million Americans in the United States, how many of them do you think are really active market participants? Meaning for every dollar of value creation or destruction, how much do they actually see? I would guess it's less than 10%, meaning 90 cents of every dollar are nameless, faceless organizations in a financial infrastructure. I think the lesson we have to tell and the place we have to move to is one of compassionate capitalism, which is that we have been so hell-bent on the use of leverage, on the

• 57:53Chamath Palihapitiya?

  use of these financial gimmicks, on the use of accounting tricks to enrich a few at the sake of the many. And this is the right time where you should nationalize some of these businesses. And when they eventually do get taken back out and floated publicly, all of those proceeds should go back to the United States Treasury, who should then use it to reinforce Social Security and Medicare and everything else. Because we are going to run a multi-multi-trillion-dollar budget deficit to get out of this.

• 58:24Jason Calacanis?

  And to just give people some context here, the US national debt is at $23 trillion, $ which is $72,000 per citizen and $189,000 for each citizen who pays taxes. And we run, our spending, our budget deficit is a trillion dollars a year. We're going to talk about here, I think, a $2 trillion to $3 trillion stimulus package, which will increase the national debt load by only 10%. So it does seem like we can manage that. But, boy, was this a strategic mistake for us to run up the debt during good times, was it not?

• 59:02Chamath Palihapitiya?

  It's even simpler than this. And I hate to say this so bluntly, but the eurozone is going to collapse. Okay? Japan is finished. So there are two economies that matter. There's China and the United States as of today. And the great thing about that is, in a set of two, there's only one instrument of safety, which is the United States dollar. Thank God. In that world, the United States has exceptional leverage. Exceptional, exceptional leverage. It is, and it has always been, you know, the beacon, the light on the hill, et cetera. Now, in a moment like this, the United States has the most ability to reset how we think

• 59:47Chamath Palihapitiya?

  about things. It could run $5 trillion deficits tomorrow. It could run $10 trillion deficits because it is still the backstop. I'm not advocating for that, but this is where I think you need bold, decisive action and not piecemeal strategies. I don't think a trillion dollars is enough. I really think that if you think about what the eurozone will have to do and what's going to happen to the US dollar, we should be basically saying, right off the bat at a minimum, anyone who makes less than, you know, pick your number, a million dollars a year. Every man, woman, and child, every or every 18-year-old American man and woman should immediately get $5,000. Forget 1,000, 2,000, 5,000. And next month, if we're still out of business,

• 1:00:30Chamath Palihapitiya?

  5,000. And all of that does is just, it's a trillion dollars. It's 2 trillion dollars over 2 months. And then you add another trillion dollars in all this, you know, small business loans and all the other things. That's 3 trillion dollars. That you can deal with because we're the United States. And I think it's really important to keep it in mind. I know that sounds crazy.

• 1:00:47Jason Calacanis?

  Well, I mean-

• 1:00:48Chamath Palihapitiya?

  And to some people, they'll think, "Oh, you know, blah, blah, blah, you know, budgets and deficits." But it's not, because everybody else is just as fucked, if not more fucked.

• 1:00:57David Friedberg?

  Well, let me give you, let me give you another perspective. The GDP of the United States is 20 trillion dollars roughly. Every month, let's assume the whole economy shuts down. Every month that we're shut down costs us 1.5 trillion dollars. So if we're gonna have the country shut down for, say, 3 months, we're losing 4.5 trillion dollars right there. The problem is, economic growth of the economy is actually a first-order function, right? So the movement of cash drives the future economy. And so if we were just needing to fill that hole, you would need to come up with a couple of trillion dollars, and you would have the government going out and buying ice cream cones and paying hair salons

• 1:01:42David Friedberg?

  and paying for dog walkers and, you know, paying for construction workers and paying for oil rig workers and basically, basically employing and buying all of those goods and services for that functional equivalent of a 20 trillion dollar GDP. That's what it would take to just fill the hole.

• 1:01:57Jason Calacanis?

  Well, that's if you're assuming no economic activity. I mean, we don't think there's gonna, there's gonna be no economic activity. Maybe, let's say it's a third less economic activity?

• 1:02:07Chamath Palihapitiya?

  Jason, the shoe, guys, the shoe that hasn't dropped is this idea that everybody is at home working. Nobody's at home working. That's a joke. That's a lie.

• 1:02:19Chamath Palihapitiya?

  Okay, because as David said, companies are not self-contained units, very few are. Many of them and most of them operate in a very interconnected socially dependent way with other companies. They're your customers, you are their customers. Nobody is doing anything right now. There's nobody evaluating the next great SaaS tool. Guys, come on.

• 1:02:41David Friedberg?

  And the other issue is just leverage, Jason, right? So we've also got to remember that a big chunk of the economy is levered, meaning that there's debt and debt payments that need to be paid. And so those income streams are now going to be absent. And so there's a multiplier effect. When revenue goes down, the economic impact is actually multiplied. And so you can't just fill the hole. So it becomes a very complicated nonlinear kind of system that you have to try and fill the holes and you got to find the places where cash is missing and it's not moving the fastest. And that's where you got to throw the money in the first, like these repo markets and so on.

• 1:03:15Jason Calacanis?

  Well, and there's no doubt that we all agree bottom up is the way to do this. So if we have 330 million Americans, if you just have the bottom half get $1,000 a month, that's call it $160 billion a month. That's only over the year $2 trillion. So if we just did that and gave everybody $1,000 a month, that's $12,000 for the bottom half. They're not saving that money. They're going to use it to, they're going to spend it in the market, correct? They're going to pay their rent, they're going to go get dinner.

• 1:03:38Chamath Palihapitiya?

  I don't think so.

• 1:03:38Jason Calacanis?

  You think that poor people are going to, who are laid off right now are going to save the money?

• 1:03:43Chamath Palihapitiya?

  Well, if you gave me $1,000 or somebody $1,000 when they're in their house on the sixth week of their home confinement, what you think there is like?

• 1:03:53Jason Calacanis?

  Well, I'm assuming that we're in week 10 and we're not in self-confinement anymore. We agreed in the first third of the program that we're going to get there in whatever it is, 60 days, 90 days.

• 1:04:02Chamath Palihapitiya?

  You know what I've realized? You know what I've realized after wearing the same pair of jeans four days in a row? I have too many jeans. That's what I've realized. And you know what I've also realized? That the cotton shirts that I buy from H and M are fucking perfect. And I've complicated my life with all kinds of bullshit that I've been buying because I thought it meant something. And right now it means absolutely jack shit.

• 1:04:28Jason Calacanis?

  Yeah.

• 1:04:29David Friedberg?

  Yeah, I'd agree with that perspective.

• 1:04:31Jason Calacanis?

  That's what's really interesting. When you see your entire portfolio collapse, when you see this belt tightening, it's happening even amongst, and we have, you know, listen, all three of us are lucky enough to be at the, you know, in the top of our careers and top of our income at this point in our lives, but we all came from humble beginnings as well. And if, if the people at the top are belt tightening and saying, you know what, I don't need to buy a $60 t-shirt, I'm going to buy a $16 t-shirt. Boy, does that have ramifications across the entire economy. And this reminds me very much of the recession. They said luxury goods would never rebound. And sure enough, the last 10 years, luxury rebound, luxury has rebounded massively.

• 1:05:09Chamath Palihapitiya?

  Because it was not a psychological, broad-based impact to people's philosophy and framing of how they viewed the world.

• 1:05:17Jason Calacanis?

  You think so? I don't. After the economic crisis last time, people did say there would never be, people specifically said there would never be luxury goods again. And that it was the end of people buying that kind of shit.

• 1:05:26Chamath Palihapitiya?

  I'm not talking about some prognosticating analyst, you know, the analyst is only as, you know, good as their own biases. What I'm saying is, the average person didn't really have to internalize a broad-based impact to their way in which they view what's important in their life. This touches everybody. And I think that there is an opportunity for us to really recalibrate what's important. I think conspicuous consumption is unimportant. You know, helping each other is important. Taking, you know, unnecessary vacations because it drives your Instagram

• 1:06:07Chamath Palihapitiya?

  follower feed is fucking stupid. Making sure that we can contribute the incremental dollar we have so that other people could get tested and get back to work, that seems like a better use of your money and time.

• 1:06:18Jason Calacanis?

  Yeah.

• 1:06:20Chamath Palihapitiya?

  So.

• 1:06:21Jason Calacanis?

  No, go ahead, David. Get in there.

• 1:06:24David Friedberg?

  I think that there, yeah, there's just great perspective setting that's happening and is going to happen broadly across the economy. We've been fat and happy for a long time, and at least a subsegment of the population has been. But we also have it really, really well, really, really good here in the United States. There's a website I just recommend everyone check out and spend some time on. It's called Dollar Street. And you can go to gapminder.org/dollar-street and check out the website. It is unbelievable, and it is probably my favorite website on the internet. And Dollar Street is a project of Ola Roessling's wife. Ola's the son of Hans Roessling, the great visual economist who told people stories

• 1:07:07David Friedberg?

  with visuals on like, the world and income and population and growth and so on. And she went around and she photographed families all over the world and showed how much money they make each month. And then showed all these common household activities and goods, brushing your teeth, the oven, how do you, what kind of clothes you have, what does your closet look like, what do you sleep on? And it's pretty striking that half of the people don't have a toothbrush, a quarter of people use mud off the floor to brush their teeth, most people don't have a bed. On planet Earth, right, only the top 1% have a kitchen, right? I mean, there's like these amazing statistics with photos that really help kind of illustrate this point. And I think that, I'm not saying that the extreme demonstration of humanity and the distribution of wealth, income, and prosperity and humanity

• 1:07:52David Friedberg?

  is as relevant here. But in all these photos, everyone's very happy and they live a happy life. And there's a great reset happen that's happening, that's underway. Happiness eventually finds itself when the delta goes from being negative to being positive again. When the delta is flat, or the delta is negative, people are getting into a worse condition, things are bad. So we're going to bottom out here, and then we're going to, you know, no matter what state we find ourselves in, we'll very quickly find ourselves back in a state of happiness, and we'll all reset with respect to Chamov's point on, hey, maybe I don't need all these jeans, maybe I don't need all this and this and this. But there's certainly like, critical, you know, needs that people have, and it's going to be pretty apparent pretty quickly, you know, how the economy and people are going to adjust to this, this new world. But there's going to be an adjustment.

• 1:08:37Chamath Palihapitiya?

  The part of this that I think is actually constructive is I do think that we're going to swing the pendulum back towards nationalized economies and away from global economies because I think this is a way that politicians all around the world, they'll characterize it in different political language. You know, some people will call it, you know, sort of like American exceptionalism if you're on the right. If you're on the left, you'll describe it in much more social terms, but they all lead to the same outcome, which is that what we have seen is that in the push to globalization, we have created too much brittle infrastructure

• 1:09:16Chamath Palihapitiya?

  that doesn't work and that we are not resilient enough. Man, we are hyper efficient and we are just in time and all of that is great and everything is super cheap. But when we really need infrastructure to work, whether it's tests or whether it's the government or what have you, it just doesn't. And I think resiliency will force us to be more nationally attuned. And I think it'll be the right thing. It'll cause all governments to think about their own food supply differently, to think about their own supply chains differently. It'll demand companies to be less profitable if it means that they can withstand these kinds of shocks. And it's one thing to say that we could never have modeled, you know, sort of like this two or three sigma event we're dealing with, but after the fact, it's no longer a two or three sigma

• 1:10:01Chamath Palihapitiya?

  event. And governments have to now internalize this and companies have to internalize it. We are not going to act the same. Borders will be different.

• 1:10:10Jason Calacanis?

  Look, think about the iPhone and obviously medicine and respirators. We've been talking about these things over the last, you know, couple of weeks as this happens. If we do have a breakdown in relations with China, if we, let's say we stop importing stuff, what would happen to Apple, the most powerful and valuable company? How would they ever be able to make iPhones again in the United States? Are they capable of making them?

• 1:10:35Chamath Palihapitiya?

  No, it depends. It depends on who you're answering it for. On behalf of the US customer, Apple should probably be forced to bring a lot of their production capacity back into the United States. They should find a diversified ...global supply chain so that you have multiple suppliers in many countries in the world. But they should rely more on America. It will be less profitable, but it'll be okay and it's the right thing to do.

• 1:10:57Jason Calacanis?

  Yeah, it's a hundred dollars. What I read in the estimates was an iPhone would cost a hundred or a hundred and change more to make in the United States, but if they did, they wouldn't have this supply chain issue. They make five, six hundred dollars per iPhone anyway.

• 1:11:10Chamath Palihapitiya?

  Well, by the way, the real outcome is that, you know, and we were gonna do this anyways after this, which is I don't think people are lining up to buy, you know, kind of irrelevant products anymore in a way where we're just slavish to things. I mean, I think it's important to ask ourselves, like, this is probably the most socially impactful world event that Globe has had to deal with since World War II. And it's probably really important to talk to somebody you know. And if you don't know, you can document and you can easily find the documents of people who survived the Holocaust or lived through the bombings in London, etc. Their mentality was different as a result of it. It changed their behavior in very positive ways.

• 1:11:55Chamath Palihapitiya?

  Right? It was like the great advances in humanity happened after that.

• 1:12:00Jason Calacanis?

  It was getting refocused. Yeah, you're less focused on things that are not core or critically important. And Friedberg, what do you think about what this is showing in the healthcare system and the holes in the healthcare system? The fact that we couldn't mobilize to deal with this after, we did scenario planning about this after SARS. We've done scenario planning. We've had, you know, I sent to our group list the link of Bill Gates talking about this four or five years ago and how this would be an issue. I sent a couple of links to people writing about closing the wet markets in China after the SARS outbreak. I'm curious, David, what you think the holes in the

• 1:12:45Jason Calacanis?

  healthcare system are that need to be fixed and what we can learn from this, because I think we're now coming into the, you know, as we got through the virus, we got through the economic second order effects. But let's talk about positively what we're gonna learn, because I think that's what Chamath's getting at, is that there's a personal recalibrating of what matters, maybe morality, ethics, focus in our lives. David, what can we learn from this on a health perspective? What should we do when this ends?

• 1:13:13David Friedberg?

  There's no easy answer to that, right? Nationalized healthcare systems in some countries, you could say they're great. My brother, my family lives in London. I was talking to my brother yesterday and, you know, they tried to go down and get tested for a tooth infection yesterday. And like, it's just brutal dealing with NHS in the UK. You know, people aren't telling great stories about NHS and they're not saying, "Oh my God, it's the best health system. I love it." Healthcare is hard. People want personalized care. They want a lot of attention. There's only so many doctors. There's only so much beds. When you start giving people good care, it costs a lot. Solving this stuff and the R and D dollars required to enter markets is so, you know, so extraordinarily high, you end up charging a lot for products and services on the back end.

• 1:13:57David Friedberg?

  It's a very complicated system and there's no simple answer. I do think that we're learning and realizing pretty quickly that the US, and we're gonna, we're gonna do some postmortems on this, obviously as a world, as a, as a society. One thing that's clear is the Chinese response, in part, was driven by a lack of bureaucratic red tape and an ability to manifest action and an ability to produce and distribute drugs and produce and distribute tests without needing approvals. I think that's something that's gonna change in the United States. It has to. The regulatory burden on healthcare companies, on pharmaceutical companies, on testing and diagnostics companies is extraordinarily high, but the objective in the United States has been do no harm, which means don't let anyone die through the action, but it may

• 1:14:41David Friedberg?

  be that many people are dying through the inaction. And I think we're gonna maybe see a big shift in policy and allow right to try laws that are gonna be federalized so, you know, states can make decisions about right to try laws and doctors and patients can try drugs on their own discretion without having a federal oversight body. Perhaps the same will happen with diagnostics and testing.

• 1:15:02David Friedberg?

  And with respect to what services the government provides and doesn't provide, you know, I'm not sure. There's a lot of data on either side here that nationalized healthcare systems do and don't work. So it's very hard to say what the right solution is here. And I don't think that you want to try and take R and D and put it in the government. I think that's a terrible idea. I think that there's a financial and a capitalistic motivation to find, discover molecules, get them tested and prove that they have a positive effect in human health. And we need to move this towards personalized medicine, which actually changes the construct and probably increases the cost of doing this about 10x. We're already seeing this with stem cell therapies and CRISPR-based gene therapies. Is there so much more expensive? In order to get that stuff moving faster,

• 1:15:47David Friedberg?

  we need to remove the regulatory burden and allow companies the ability to move quickly and make this stuff more affordable. The more barriers we put in front of companies, the harder it's going to be. And if we try to do this with a top-down approach, with the government deciding what to do R and D on and what not to do R and D on, we're going to be in a fucking mess. So those are some of my points.

• 1:16:07Chamath Palihapitiya?

  Yeah, I would say as well, I think that there has to be, you know, after the great financial crisis, we smartened up about what the banks were allowed to do. Unfortunately, we didn't really smarten up about what other financial participants were allowed to do. And a lot of what we're seeing here is our excesses around leverage and credit. And I think we need to fix those. We need to tell companies that, you know, you can't put out certain amounts of debt. We need to be a little draconian actually to reset this properly. We need to tell, you know, market participants that you can't run 10 or 13 times levered. You can't take $100 billion and make it act like 1.3 trillion

• 1:16:52Chamath Palihapitiya?

  and then blow a 50% hole in it. You're just not allowed to do that. I'm just sorry, but nobody should be allowed to do that.

• 1:17:00Jason Calacanis?

  Okay, so if we look now onto politics, which is the least fun to talk about in many ways. But just on international relations, I think it's worth discussing. There's been a bit of a debate about what we call this virus and the relationship between the United States and China. China went on a little bit of a propaganda campaign the last couple of days, saying that the US created the virus. Trump has now been trolling them actively, talking about the Chinese virus. I used the other day, the Wuhan virus. I didn't realize that people consider that racist to say Wuhan virus, because we called it the Spanish flu and we called it the German measles. But I guess people are particularly sensitive to this topic now.

• 1:17:43Jason Calacanis?

  And I think there is a critical issue here that I don't understand why we're not talking about this, but wet markets specifically, trade in exotic animals. These viruses are contained in certain animals like bats, which are, you know, together in flocks of like thousands and the viruses. And then these animals in wet markets, if people don't know what that is, you can Google it if you're not squeamish. But essentially, in Chinese culture, as I've read it in the Wall Street Journal and in the World Health Organization's advisements to cancel and to shut down wet markets, then there's unanimous agreement on this from the health officials that these have to be shut down.

• 1:18:27Jason Calacanis?

  Chinese culture says, we don't want to see meat in a package, because we believe it's counterfeited, it's been frozen, and it won't be as tasty, and it won't have the same nutritional properties. So you must slaughter the animal in front of us, at least for some significant percentage of the population. There, it's a tradition. And this is where these viruses have uniformly been generated from. And now we have the president and China going at each other. And we have to have this very delicate conversation, I think, David, and I'm curious, I see your position on this, because it's now hitting like a racial and, you know, and a bias. Against a certain culture is how this is being framed by the left, which is just maddening because it's actually a culture.

• 1:19:12Jason Calacanis?

  It is a cultural issue that has to end, just like our cultural tradition of shaking hands obviously needs to end or be deprecated in some severe way. So David, maybe you could talk a little bit about what you think the outcome here is on a political basis in relation to those wet markets and China and US relationships.

• 1:19:29David Friedberg?

  Look, I think China suffered heavily. I'm sure they're good. I've heard they're going to shut down the wet markets, but all I know is what I've read on the internet. So, you know, I think they're fucking awful and stupid and they should be shut down. Cultural, you know, dependence aside. There's another issue in China. Apparently there are a huge amount of the impoverished communities in China are encouraged to actually grow and harvest rats. I don't know if you guys are aware of this, but there's a bamboo rat business where you grow these rats inside of bamboo and then you kill them and you sell them. And so the poorest people in China make money growing and selling rats, rat meat. And the Chinese government just in the last week has told them to stop, which actually is a huge effect on many millions of families who are growing these rats. So there's an economic effect, but it's obvious that it's a terrible health effect.

• 1:20:15David Friedberg?

  But I'm not sure that getting rid of the wet markets truly eliminates or eradicates the risk of a new viral outbreak, right? Like, I think I mentioned to you guys on our text stream the other day, you know, 40% of the bacteria in the oceans are killed every day by viruses. This is a great stat that Jennifer Doudna uses in her book on the discovery of CRISPR. And there's 10 to the 28th bacteria in the oceans. So half of them, they all get killed every other day, every two days by viruses. There are viruses everywhere. They are going to emerge, they are going to hit us. The issue isn't necessarily where the source of the virus is coming from. It's just that we have to have better testing and diagnostics and preparedness and treatment plans and an ability to motivate and mobilize ourselves to address pandemics like this in the future.

• 1:20:59David Friedberg?

  With respect to the relationship with China, I'm not an economist. I'm not a trade guy. I don't really know the nature of the relationships, so I'll leave that to tomorrow.

• 1:21:10Chamath Palihapitiya?

  No, my thought on this is that this is not a question of, you know, wet markets or no wet markets. I think this is a question of if you are a, um, an anchor participant of globalization and the global economy.

• 1:21:24Chamath Palihapitiya?

  Is there an expectation to have a common set of behaviors, a lowest common denominator set of behaviors and hygienes that everybody signs up for to be a fully fledged global market participant? Now, the pros of that is that maybe everybody decides to be a participant and to have lax borders and free trade agreements, that there can be no wet markets and a whole host of other things. We all agree on whether we are okay with shaking hands or maybe it's namaste from now on, or maybe it's bowing. The problem with that, on the other side, is that all of a sudden you create a monoculture that strips away the individuality and the richness of every country.

• 1:22:09Chamath Palihapitiya?

  And I kind of think that we could have attacked wet markets when HIV started to spread because it was, as we understand it, it was the emergence of bushmeat and raw bushmeat and the killing of monkeys that had this virus that was then passed to humans, et cetera, et cetera, that started the HIV epidemic. So these things have happened before. And it's not as if we shut down all of those markets in Africa. They still exist in some form or fashion. And as David said, there are huge economic ramifications to having these cultural edicts. And it's very difficult, I think, for an American to demand China to do it when we're not willing to step up, just like in other ways, countries can demand us

• 1:22:53Chamath Palihapitiya?

  to lower our carbon emissions and we say we're not going to do it. So there are implications and very difficult issues all over the place. But I do think, in general, that if we move towards a more nationalistic economic dependency, interdependency, I think that it's probably the right thing to allow more resilience to exist and for cultural diversity to continue to compound.

• 1:23:29Chamath Palihapitiya?

  Because the world of just-in-time efficiency, I think we're learning now was the wrong optimization for the world. We need to optimize for resiliency, and that means some amount of inefficiency. It means more mom-and-pop shops. I think that that's a good thing. It doesn't mean everything is Amazon Prime Now and Walmart. I think that's okay. It means that the iPhone is a little bit more expensive, which means you upgrade every other year. That's okay. It means that companies like Google and Facebook and others are less profitable in the short term. That's also okay. All of these things are okay. We just need to decide, and now we need to move forward.

• 1:24:12Jason Calacanis?

  When do we, what's our best estimate of when people will be allowed to go to a restaurant? I think it's, you know, again, getting back to what the people listening to this podcast probably care about most as we wrap up here in the, in the second hour. And thank you for tuning into the All In Podcast. David Friedberg is with us from, what's the name of your incubator again? David?

• 1:24:34Chamath Palihapitiya?

  The Production Board.

• 1:24:36Jason Calacanis?

  The Production Board, previously Metromount Climate dot com, and Shamaat Palihapatia of Social Capital Partnership. When do we suspect people will be allowed to go back to work in the Bay Area in New York? When will people be able to go and have a meal in a restaurant? Do you think this is May, June, or July, or August? When will we be at a quarantine?

• 1:24:58Chamath Palihapitiya?

  I'll give you my

• 1:24:59Jason Calacanis?

  I'm going crazy.

• 1:25:00Chamath Palihapitiya?

  I'll give you my optimistic, and then we can give the final word to David. Here's my optimistic view.

• 1:25:07Jason Calacanis?

  Please, I'm dying.

• 1:25:09Chamath Palihapitiya?

  I think that the emerging evidence will soon be hard to ignore that we have a denominator problem, which means that we're not testing enough, and that these IGG and IGM tests will come online at scale in the next two weeks. And that we will establish demarked zones within cities and towns, green zones, if you will, where people who are either negative or who have already gotten and have tested positive for the antibodies will be allowed to interact. So I am telling you that it's within six weeks from now.

• 1:25:44Jason Calacanis?

  Six weeks from now, we'll be in restaurants and we may have to show our papers to somebody to get in or have our foreheads tested.

• 1:25:53Chamath Palihapitiya?

  No, no, you just have to show your test result and have your passport or driver's license.

• 1:25:58Jason Calacanis?

  Yeah, I mean, I know this sounds crazy. I would much rather go to a restaurant in the next six weeks where I had to show my papers, a little bit draconian, sounds a little dystopian. I would much rather go back to Taisho and have my goddamn ramen, show my papers and know everybody else did, and then have everybody go through the, you know, very simple temperature test on their forehead like I give to my kids when they're sick. David, you taking the over or the under at six weeks for when we'll all be at Taisho and having ramen?

• 1:26:27David Friedberg?

  I'm taking the under. I'm taking April 7th or 8th.

• 1:26:32Jason Calacanis?

  April 7th or 8th, and we're recording this, I think, on the 17th or the 18th, I think. And so you're saying we're just going to be, whatever, 20 days out. I too am taking the under, but barely. I think it's, I think we're four or five weeks.

• 1:26:45Chamath Palihapitiya?

  David, David, explain the under case, just so, and we can end on that. But what's the under case? Because that's a great note to end on.

• 1:26:50David Friedberg?

  Yeah. So as we see the number, if you look at the UW virology website, and I've shared this with people on my Twitter account, which I started doing yesterday.

• 1:26:59Jason Calacanis?

  Which is at Friedberg.

• 1:27:01David Friedberg?

  At Friedberg. I'm not sure I'm going to stick with it. I don't know if I have the stomach for it like you guys do. But basically, they're showing, you know, steady caseloads of positives per day, which again is delayed. And if you look at the ICU availability, the emergency room wait time data, which I think are better leading indicators of where we are in the cycle. New York is about two weeks behind us. New York is going to be fucked for a little while. But I do think that the West Coast and with some travel restrictions is going to be able to reopen for business probably around April 7th or 8th, because we're going to see a dramatic decline at that point. And we're going to see a lower fatality rate than everyone is predicting and we're Start to have measures around washing your hands and masks because you can't stay shut down for that long without literally never being able to open again.

• 1:27:45David Friedberg?

  So I'm kind of balancing the economic need against what I think the data is starting to show. That hopefully we are seeing the second derivative turning negative now. And so we start to see a slowdown in new cases and then we see a reduction in cases. And I think that, you know, there's a huge distribution on what that model can tell you. But I feel really good about kind of April 7th or 8th, us getting enough confidence that, okay, it's safe to go outside again. And by the way, if we don't open up for fucking business, everyone's done forever.

• 1:28:16Jason Calacanis?

  All right.

• 1:28:16David Friedberg?

  So that's where I get the number.

• 1:28:18Jason Calacanis?

  And most importantly, when do we feel comfortable playing cards again in person? Because I'm, I'm starting to think that I want, I know this sounds crazy. But at this point, if the three of us were positive and we'd gotten through it already, I would like to know that. I think the entire poker group needs to get tested. And the best possible scenario is that we're all inoculated. We're not carriers anymore. We're blockers in the system and we can get back to playing cards. Because I am, and I'm being a little facetious here, but the chances are we might all have it, right? I mean, it's a possibility. I am going bonkers being at home. I am not designed for social isolation. I am going crazy.

• 1:28:57David Friedberg?

  Jamath, do you like it?

• 1:28:59Chamath Palihapitiya?

  Yeah, I mean, I'm a, I'm a pretty isolated person as a matter of course anyway. So other than work and, you know, my, doing this or TV, I'm always at home.

• 1:29:08Jason Calacanis?

  Yeah.

• 1:29:09Chamath Palihapitiya?

  And, but the, the one thing that I cannot live without is Monday pokers. And I'll really tell you why. It's like, in a moment like this, here's, here's what I've realized. I've realized just how much extraneous stuff I have in my life, how much I don't need it, how much I've occupied my time with things that are just not important. And it's really allowed me to clarify, like, you know, working on the next deal, not important. Thinking about my status in society, not important. Thinking about what other people think of me, not important. My health, important. Um, my family and their health important and my friends, I love my friends.

• 1:29:52Jason Calacanis?

  Yeah, we're very blessed.

• 1:29:54Chamath Palihapitiya?

  I, I mean, I, I love the both of you. That group, uh, saved me in some really tough moments in my life.

• 1:30:01Jason Calacanis?

  Yeah.

• 1:30:02Chamath Palihapitiya?

  And I hate not seeing you guys and being able to, you know, just touch and feel you, uh, on, on, um, uh, once a week. It's, that to me is brutal.

• 1:30:11Jason Calacanis?

  And just to be clear, this is a poker group when we, when we define touching and feeling, uh, we're talking about poker chips.

• 1:30:18Chamath Palihapitiya?

  It's fine. We make man love.

• 1:30:19Jason Calacanis?

  We make man love over the poker table and that's how men commune is by just shifting large amounts of money across the table. I miss you guys too. I'm going crazy.

• 1:30:28Chamath Palihapitiya?

  I, I'm not going to be, I, I don't think like you're going to see me after this said and done. I can't take seriously buying things. I just think it's like, what the fuck is the point?

• 1:30:37Jason Calacanis?

  Um, yeah.

• 1:30:38Chamath Palihapitiya?

  I really take seriously that we need to fix the social infrastructure of the United States and in part do our, do what we can to help as many people as possible.

• 1:30:48Jason Calacanis?

  All right. They have it folks. Chamath Friedberg, 2024. Uh, hey, David Friedberg.

• 1:30:53Chamath Palihapitiya?

  Love you both.

• 1:30:53Jason Calacanis?

  Thanks a lot for doing this, Chamath. Thanks a lot for doing this. Follow at Chamath, follow at Friedberg. If you want to help out the podcast, uh, well, there's no ads to, uh, click on because Chamath wants me to go broke on this. Uh, no ads, but, uh, I will say if you write us a five star review on iTunes, I guess that means we'll get indexed. And follow Friedberg, follow at Chamath, follow at Jason. We'll see you all next time. Bye bye.